Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a snapshot looking at the growing global opportunity for CBD consumable products as regulations move towards global acceptance of CBD products.
Cannabis is fast becoming a growing sector, both in the medicinal and recreational sectors. As much as certain states and countries have begun to regulate this potential giant industry, CBD and specifically hemp strains of cannabis have begun to overshadow the general cannabis sector.
Seeing the opportunity at the start of 2018, EnviroTechnologies International, Inc., a publicly traded company (OTC:ETII) that develops and markets green, natural and organic products for diverse industries first announced the acquisition of CBD Health Co. (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, as a wholly owned subsidiary.
One of the products that uniquely position them as a public company is the CBD Hemp Protein, which caters to the health and sports markets. According to an article discussing its benefits “hemp–one of the most versatile plants on earth–offers a high-quality, eco-friendly source that can support muscle gain, fat loss, and peak performance.”
EnviroTechnologies International updated shareholders on this acquisition in today’s news. “We acquired CBD Health Co. because our company was founded to use green and natural products to make our environment safer and promote products that improve our quality of life,” said Gaylord Karren, ETI’s CEO. “And CBD Oil products have the potential to not only improve quality of their users’ lives but also create enormous revenues for our company and its shareholders.”
Continued: “For some time, experts have been making predictions about the global CBD market and the expanding acceptance of CBD as a natural health product. And some have predicted, specifically that the entire cannabis market could reach $20 billion by 2020 if the market expands at its current rate,” said Randall Waters, ETI’s Vice President of Sales and Marketing. “However, recent studies by the Brightfield Group, a company that specializes in providing data and information about the cannabis and CBD markets, avers that the hemp-based CBD market alone could reach $22 billion by 2022.”
Continued: “We see the markets for true hemp-based CBD products such as those produced by CBD Health, continuing to grow and the purchasing demographic multiplying over the next 3-4 years. We are satisfied that CBD Health is on the forefront of this incredible market and that we can tap into this new, accepted hemp-based CBD natural products,” said Waters.
Puration, Inc. (OTC:PURA), another company in the CBD space, recently released more details regarding its corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business.
Puration, Inc. is a leading Texas-based CBD-infused beverage provider, with the flagship product being EVERx, which Puration debuted early last year at Arnold Schwarzenegger’s ‘Arnold Sports Festival’. EVERx has since become the leading CBD infused beverage in the sports nutrition marketplace. The Company recently spun-off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.
CV Sciences Inc. (OTC:CVSI), operates as a life science company through two segments, Specialty Pharmaceuticals and Consumer Products. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods and vape.
CEO Joseph Dowling discussed the company’s Q3 Earnings Report earlier this month saying that, “The momentum from the first half of 2018 has continued and we anticipate a strong finish for the remainder of the year. Through our dedication and commitment to providing the most trusted brand of hemp CBD products we have achieved strong momentum in sales and brand recognition of our plus CBD product line. Our strategic priorities for 2018 include strengthening our distribution channels, growing our brand relevance and recognition, developing new products, penetrating new vertical sales channels and gaining market share in the fastest growing product category in the nutritional supplement industry.”
Even larger scale companies such as the Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTC:TGODF) earlier this year expanded their CBD output by signing a definitive agreement to acquire 100% of the issued and outstanding shares of privately-held HemPoland.
HemPoland is a leading European manufacturer and marketer of premium organic CBD oils led by founder and CEO, Maciej Kowalski, one of Europe’s most widely recognized CBD experts. This strategic acquisition provides access to HemPoland’s vast distribution network, premium Cannabigold brand, state-of-the-art hemp oil extraction technologies and provides a strategic pathway into the European market for TGOD’s medical & recreational products and licensing deals.
As the CBD trend continues to rise, companies may realize the benefit of focusing strictly on the CBD/Hemp sector. Often noted as a sleeping giant in discussions, consumer awareness and education, plus potential legislative acceptance moves, including the 2018 Farm Bill, will make this a big story for investors moving forward.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com – News that Inspires Big Investing Ideas
Follow us on Cannabis Social Media
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com – third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0MzYwMjI=” alt=”” width=”1″ height=”1″/>